Home Biosimilar Antibodies Immunology & Inflammation CD markers antibody Lintuzumab (Anti-Siglec-3 / CD33) For research use only.
Not for use in humans.

Lintuzumab (Anti-Siglec-3 / CD33)

Synonyms: HuM195

Lintuzumab (HuM195) is a humanized monoclonal antibody that targets CD33, a 67-kDa cell surface glycoprotein expressed on most myeloid leukemia cells. MW: 145. 24 kD.

Lintuzumab (Anti-Siglec-3 / CD33)

Purity & Quality Control

≥99

Choose Selective CD markers Inhibitors

Biological Activity

Description Lintuzumab (HuM195) is a humanized monoclonal antibody that targets CD33, a 67-kDa cell surface glycoprotein expressed on most myeloid leukemia cells. MW: 145. 24 kD.

Product Details

CAS No. 166089-32-3
Molecular Weight 145.24
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Lintuzumab (Anti-Siglec-3 / CD33) | Lintuzumab (Anti-Siglec-3 / CD33) supplier | purchase Lintuzumab (Anti-Siglec-3 / CD33) | Lintuzumab (Anti-Siglec-3 / CD33) cost | Lintuzumab (Anti-Siglec-3 / CD33) manufacturer | order Lintuzumab (Anti-Siglec-3 / CD33) | Lintuzumab (Anti-Siglec-3 / CD33) distributor